BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 11908560)

  • 1. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics.
    Omdal R; Mellgren SI; Koldingsnes W; Jacobsen EA; Husby G
    J Rheumatol; 2002 Mar; 29(3):482-6. PubMed ID: 11908560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P; Gómez J; Prado C; Gutiérrez C; Suárez A
    J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
    Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
    Bakri Hassan A; Rönnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I
    J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.
    Lacki JK; Leszczynski P; Kelemen J; Müller W; Mackiewicz SH
    J Med; 1997; 28(1-2):99-107. PubMed ID: 9249616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
    Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
    Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proinflammatory cytokines in inactive lupus erythematosus patients].
    Lesiak A; Sysa-Jedrzejowska A; Narbutt J; Lukamowicz J; Robak E; Wozniacka A
    Przegl Lek; 2005; 62(9):838-42. PubMed ID: 16541713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
    Neidhart M
    J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation.
    Waszczykowska E; Robak E; Wozniacka A; Narbutt J; Torzecka JD; Sysa-Jedrzejowska A
    Mediators Inflamm; 1999; 8(2):93-100. PubMed ID: 10704146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.